Skip to content
NBDC Human Database

No datasets in the cart.

Go to the cart

Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Dataset ID

JGAD000773

Type of data
NGS (WGS, RNA-seq)
Access criteria
Controlled-access (Type I)
Total data volume
85.9 GB
File formats
  • FASTQ
Research
hum0429
Date published
2023-10-31
Date modified
2023-10-31
DDBJ Search
JGAD000773 (opens in a new tab)
JGA Study
JGAS000643 (opens in a new tab)

Analysis method

WGS

Materials and participants
tumor tissue collected from LU99 tumor-bearing mice: total 16 samples
tumor tissue collected from mice with treatment (JDQ443 + TNO155 + alpelisib + ribociclib) / vehicle condition at 3 hours / 24 hours after the last dose: 4 samples each
  • Health status
    Affected
  • Subject count
    24 (Sample)
Disease
human lung cancer (C349)
Sample description
DNAs extracted from tumor tissues
  • Tumor / normal
    Tumor
Cell line
LU99
Sample provider
https://cellbank.brc.riken.jp/cell_bank/CellInfo/?cellNo=RCB1900
Experimental method
WGS
Target
N/A
Reagent kit
NEBNext Ultra II DNA PCR-free Library Prep Kit for Illumina
Fragmentation
Ultrasonic fragmentation (Covaris)
Platform
Illumina NovaSeq 6000
Read type
Paired-end
Read length
51 bp
Data use policy
NBDC data sharing policy (JGAP000001)

RNA-seq

Materials and participants
tumor tissue collected from LU99 tumor-bearing mice: total 16 samples
tumor tissue collected from mice with treatment (JDQ443 + TNO155 + alpelisib + ribociclib) / vehicle condition at 3 hours / 24 hours after the last dose: 4 samples each
  • Health status
    Affected
  • Subject count
    24 (Sample)
Disease
human lung cancer (C349)
Sample description
RNAs extracted from tumor tissues
  • Tumor / normal
    Tumor
Cell line
LU99
Sample provider
https://cellbank.brc.riken.jp/cell_bank/CellInfo/?cellNo=RCB1900
Experimental method
RNA-seq
Target
N/A
Reagent kit
Illumina Stranded Total RNA Prep, Ligation with Ribo-Zero Plus
Fragmentation
Enzymatic fragmentation
Platform
Illumina NovaSeq 6000
Read type
Paired-end
Read length
50 bp
Data use policy
NBDC data sharing policy (JGAP000001)